Mark Pogson

456 total citations
12 papers, 305 citations indexed

About

Mark Pogson is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Mark Pogson has authored 12 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Oncology. Recurrent topics in Mark Pogson's work include Monoclonal and Polyclonal Antibodies Research (6 papers), CRISPR and Genetic Engineering (3 papers) and Bacterial Genetics and Biotechnology (3 papers). Mark Pogson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), CRISPR and Genetic Engineering (3 papers) and Bacterial Genetics and Biotechnology (3 papers). Mark Pogson collaborates with scholars based in United States, Switzerland and Greece. Mark Pogson's co-authors include George Georgiou, Brent L. Iverson, Sai T. Reddy, Ulrike Menzel, Tarik A. Khan, Victor Greiff, Simon Friedensohn, William Kelton, Ulrike Haessler and Juan C. Almagro and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Nature Communications.

In The Last Decade

Mark Pogson

12 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Pogson United States 10 240 116 85 45 36 12 305
Hervé Nozach France 13 184 0.8× 132 1.1× 64 0.8× 72 1.6× 28 0.8× 23 354
Louis Bisson Canada 11 338 1.4× 110 0.9× 68 0.8× 43 1.0× 107 3.0× 15 440
Robert Weik Austria 11 367 1.5× 156 1.3× 73 0.9× 22 0.5× 58 1.6× 13 492
Valérie Calabro United States 8 269 1.1× 145 1.3× 75 0.9× 28 0.6× 30 0.8× 12 353
Peer Stehling Germany 8 403 1.7× 69 0.6× 107 1.3× 82 1.8× 36 1.0× 9 470
Natalia I. Majewska United States 9 464 1.9× 155 1.3× 59 0.7× 29 0.6× 63 1.8× 12 525
Christian Y. Arod United States 7 200 0.8× 81 0.7× 82 1.0× 33 0.7× 25 0.7× 9 305
Kathryn E. Tiller United States 6 301 1.3× 273 2.4× 64 0.8× 43 1.0× 11 0.3× 6 386
Steven Lang United States 9 377 1.6× 53 0.5× 34 0.4× 66 1.5× 101 2.8× 11 436
Kip Dudgeon Australia 9 472 2.0× 402 3.5× 74 0.9× 72 1.6× 20 0.6× 11 563

Countries citing papers authored by Mark Pogson

Since Specialization
Citations

This map shows the geographic impact of Mark Pogson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Pogson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Pogson more than expected).

Fields of papers citing papers by Mark Pogson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Pogson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Pogson. The network helps show where Mark Pogson may publish in the future.

Co-authorship network of co-authors of Mark Pogson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Pogson. A scholar is included among the top collaborators of Mark Pogson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Pogson. Mark Pogson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Appelbaum, Jacob, April E. Price, Joy Zhang, et al.. (2021). Clinical Translation of SC-DARIC33: A Pharmacologically Controlled CD33-Targeted Anti-AML CAR T Cell Product Regulated By Low Nanomolar Concentrations of Rapamycin. Blood. 138(Supplement 1). 905–905. 1 indexed citations
2.
Kelton, William, et al.. (2017). Reprogramming MHC specificity by CRISPR-Cas9-assisted cassette exchange. Scientific Reports. 7(1). 45775–45775. 15 indexed citations
3.
Lambert, Abigail R., Kyle Havens, Mark Pogson, et al.. (2017). Crystallographic analyses illustrate significant plasticity and efficient recoding of meganuclease target specificity. Nucleic Acids Research. 45(14). 8621–8634. 11 indexed citations
4.
Pogson, Mark, et al.. (2016). Immunogenomic engineering of a plug-and-(dis)play hybridoma platform. Nature Communications. 7(1). 12535–12535. 37 indexed citations
5.
Greiff, Victor, Ulrike Menzel, Ulrike Haessler, et al.. (2014). Quantitative assessment of the robustness of next-generation sequencing of antibody variable gene repertoires from immunized mice. BMC Immunology. 15(1). 40–40. 51 indexed citations
6.
Menzel, Ulrike, Victor Greiff, Tarik A. Khan, et al.. (2014). Comprehensive Evaluation and Optimization of Amplicon Library Preparation Methods for High-Throughput Antibody Sequencing. PLoS ONE. 9(5). e96727–e96727. 39 indexed citations
7.
Σκρέτας, Γεώργιος, Tomohiro Makino, Navin Varadarajan, Mark Pogson, & George Georgiou. (2012). Multi-copy genes that enhance the yield of mammalian G protein-coupled receptors in Escherichia coli. Metabolic Engineering. 14(5). 591–602. 24 indexed citations
8.
Yoo, Tae Hyeon, Mark Pogson, Brent L. Iverson, & George Georgiou. (2012). Directed Evolution of Highly Selective Proteases by Using a Novel FACS‐Based Screen that Capitalizes on the p53 Regulator MDM2. ChemBioChem. 13(5). 649–653. 25 indexed citations
9.
Σκρέτας, Γεώργιος, Tomohiro Makino, Navin Varadarajan, Mark Pogson, & George Georgiou. (2012). Multi-Copy Genes that Enhance the Yield of Mammalian G Protein-Coupled Receptors in Escherichia coli. New Biotechnology. 29. S146–S146. 1 indexed citations
10.
Pogson, Mark, George Georgiou, & Brent L. Iverson. (2009). Engineering next generation proteases. Current Opinion in Biotechnology. 20(4). 390–397. 40 indexed citations
11.
Varadarajan, Navin, Mark Pogson, George Georgiou, & Brent L. Iverson. (2009). Proteases That Can Distinguish among Different Post-translational Forms of Tyrosine Engineered Using Multicolor Flow Cytometry. Journal of the American Chemical Society. 131(50). 18186–18190. 16 indexed citations
12.
Almagro, Juan C., et al.. (2008). Synthetic Antibody Libraries Focused Towards Peptide Ligands. Journal of Molecular Biology. 378(3). 622–633. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hervé Nozach Breakdown of academic impact, for papers by Louis Bisson Breakdown of academic impact, for papers by Robert Weik Breakdown of academic impact, for papers by Valérie Calabro Breakdown of academic impact, for papers by Peer Stehling Breakdown of academic impact, for papers by Natalia I. Majewska Breakdown of academic impact, for papers by Christian Y. Arod Breakdown of academic impact, for papers by Kathryn E. Tiller Breakdown of academic impact, for papers by Steven Lang Breakdown of academic impact, for papers by Kip Dudgeon
Rankless by CCL
2026